Skip to main content
. 2020 Dec 31;10:22436. doi: 10.1038/s41598-020-80288-z

Figure 4.

Figure 4

Colorectal cancer cells expressing NAT2_5 and NAT2_14 but not NAT2_7 are sensitive to APA treatment. (AC) Quantification of NAT2 catalytic activity in RKO clones expressing (A) NAT2_5, (B) NAT2_7 and (C) NAT2_14 enzymatic variants. The velocity at which APA becomes acetylated was measured by LC–MS/MS at different concentrations. A representative experiment is shown for each enzymatic variant. (DF) Dose response for APA in RKO clones expressing the (D) NAT2_5, (E) NAT2_7 and (F) NAT2_14 enzymatic variants. Cell viability was measured by a MTT assay after 72 h. The mean and S.D. of three independent experiments is shown. Data were analyzed using a two-way ANOVA. **p < 0.01 and ****p < 0.0001.